Connect with us

Hi, what are you looking for?

Wednesday, Apr 24, 2024
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

Business

Tilray says it’s fighting ‘ankle biters’ for sales in Q1 call

As his firm struggles to outshine his competition, CEO Irwin Simon says he’ll win over more customers by educating them on his brands in stores

Tilray says it's fighting 'ankle biters' for sales in Q1 call
Smaller Canadian cannabis firms are coming for the ankles of big weed like flesh-hungry fish. Photo by Gregory Moine via Wikimedia Commons

While other big weed CEOs like Hexo’s Sebastien St-Louis have acknowledged the larger-than-expected impact of craft producers on Canada’s pot market, in an earnings call Thursday, Tilray, Inc. (TSX: TLRY) (Nasdaq: TLRY) top boss Irwin Simon described some of his competition as mere “ankle biters” selling product on price, which his firm will dismiss by simply building its brands.

The earnings call followed the release of Tilray’s first-quarter results for the three months ended Aug. 31, which showed the company pushing up net revenue by 18 per cent to US$168 million, from US$142.2 million in the last sequential period.

Of that total, net cannabis revenue rose 30 per cent to US$70 million from US$53.7 million. The firm said it brought in US$15 million in beverage alcohol from its SweetWater business, and US$15 million from its hemp company Manitoba Harvest.

Tilray, which now also includes Aphria’s assets after a merger in May, says it maintained its number one position in market share of Canada’s pot sector, according to HiFyre retail data.

The firm reported a net loss of US$34.6 million, a 203-per-cent increase from net income of US$33.6 million last quarter.

Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) increased 3 per cent to US$12.7 million from US$12.3 million.

Tilray’s war chest shrank by 23 per cent to US$376 million in cash and cash equivalents in the quarter.

On Thursday’s call, Cowen analyst Vivien Azer asked for comment on quarterly trends in Canada’s adult-use market, particularly related to Tilray’s strategy of getting consumers to buy their products over others at retail.

Read more: Tilray confirms shutdown of flagship Nanaimo facility

Read more: Tilray moves to take large stake in US retailer MedMen

CEO Simon started by noting that stores, in Ontario, were closed due to pandemic restrictions until the latter half of June, but now they’re back open and at full capacity, which he says is good news.

“We are on the street educating budtenders about our product,” he explained. “We’re trying to do as much social media as we can to bring consumers back into the stores.”

“And with that, consumers out there want good potency, good products and what’s important is for us to be out there building our brands. And that’s the big thing, there’s a lot of little [licensed producers] out there today that are ankle biters that are selling product just on price.”

While he didn’t specify exactly who the ankle biters are, they have to include many of the small and medium firms that have come online in recent months, which in the eyes of many have driven consumer excitement for the industry overall.

Simon also said there have to be changes to regulations made, and his company will be out there lobbying politicians. He mentioned legal advertisements and amendments to current tax rules as target areas.

Simon’s comments were followed by a flurry of subtweets from some of the producers biting his ankles and their supporters.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Nick Laba on Twitter

nick@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Beverages

Revenues increased as a result of the company completing the construction of its Kelowna-based production facility

Business

The company posted a net loss of $5.8 million for Q1 2022, compared to a loss of $7 million during the same period last year

Business

The cannabis retailer expanded its store portfolio from six to 28 corporate stores by the end of January

Business

Cannabis revenue of $66 million during the fourth quarter represented a decline of 35 per cent